Results 111 to 120 of about 6,415,892 (312)
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss and the accumulation of misfolded α-synuclein, yet the underlying mechanisms remain incompletely understood. Over the past two decades, genetic
Takahiro Shimizu +3 more
doaj +1 more source
Additional file 2. Table with secondary outcomes of EQ5D-5L, VAS, NMS-Quest.
Hannink, K. +8 more
openaire +1 more source
Blood metabolomics profiling of Parkinson’s disease reveals coordinated pathway alterations [PDF]
FNR14599012 - Validating Digital Biomarkers For Better Personalized Treatment Of Parkinson’s Disease, 2020 (01/05/2021-30/04/2024) - Enrico Glaab3.
GLAAB, Enrico
core
Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows
Dopamine‐replacement therapy still stands as the most effective pharmacological strategy for the management of motor impairment associated with Parkinson’s disease.
SIMOLA, NICOLA, Nicola Simola
core +1 more source
Founding Editorial: Neuro‐Drug Discovery
Neuro-Drug Discovery, EarlyView.
Wenbin Li
wiley +1 more source
Global Rather Than Vertical‐Selective Saccadic Abnormalities in Progressive Supranuclear Palsy
ABSTRACT Objective To test whether vertical saccades are preferentially affected in Progressive Supranuclear Palsy (PSP). Methods PSP patients (n = 24) were compared to age‐matched controls (n = 94) and two degenerative groups (Alzheimer's disease, n = 20; Lewy body disease, n = 50).
Duy Duan Nguyen +6 more
wiley +1 more source
Occupational Therapy for Parkinsonian Patients: A Retrospective Study
Background. Hand functionality and finger dexterity are impaired in patients with Parkinson’s disease (PD). These disturbances lead to a dependency in activities of daily living (ADL) and poor quality of life (QoL). Objective.
Michele Franciotta +5 more
doaj +1 more source
Additional file 4: of Blood transcriptomics of drug-naĂŻve sporadic Parkinsonâ s disease patients
Square of the Mahalanobis distance calculated for each sample from both control and pathological class models. (PDF 3122 kb)
Calligaris, Raffaella +17 more
openaire +1 more source
Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton +4 more
wiley +1 more source
Quality assessment of studies included in the Meta-analysis. Criterion include five parts: 1) definition of PD diagnosis; 2) validation of PD diagnosis; 3) adjustment for confounding factors; 4) source and definition of cancer diagnoses; 5) representativeness of cases. Potential total scores ranged from 0 to 9. (PDF 127Â kb)
Huang, Pei +3 more
openaire +1 more source

